NCT02131077View on ClinicalTrials.gov

Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

August 31, 2015

Conditions

Tennis Elbow

Interventions

BIOLOGICAL

ALLO-ASC-TI

DRUG

Placebo

Trial Locations (6)

Unknown

Asan Medical Center, Seoul

Chung-Ang University Hosptal, Seoul

Gangnam Severance Hospital, Seoul

Nanoori hospital, Seoul

Samsung medical center, Seoul

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Anterogen Co., Ltd.

INDUSTRY

NCT02131077 - Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis | Biotech Hunter | Biotech Hunter